HIGH-RISK RECTAL CANCER NEO-ADJUVANT CAPECITABINE AND OXALIPLATIN BEFORE RADIOTHERAPY WITH CONCOMITANT CAPECITABINE AND RADICAL SURGERY LOCOREGIONAL RESPONSE

被引：0
|
作者：
Brodmann, S. [1 ]
Bateman, A. C.
Bateman, A. [1 ]
机构：
[1] Southampton Gen Hosp, Radiotherapy Ctr, Southampton, Hants, England
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2010年 / 186卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：724 / 725
页数：2
相关论文
共 50 条
  • [21] Early results of multicenter phase II trial of perioperative oxaliplatin and capecitabine without radiotherapy for high-risk rectal cancer: CORONA I study
    Kamiya, T.
    Uehara, K.
    Nakayama, G.
    Ishigure, K.
    Kobayashi, S.
    Hiramatsu, K.
    Nakayama, H.
    Yamashita, K.
    Sakamoto, E.
    Tojima, Y.
    Kawai, S.
    Kodera, Y.
    Nagino, M.
    EJSO, 2016, 42 (06): : 829 - 835
  • [22] Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before surgery in patients with locally advanced rectal cancer
    Azmy, Aly Mohammed
    Ghali, Ramy Refaat Youssef
    Shakweer, Marwa Mosaad
    Gobran, Nagy Samy
    Soliman, Doaa Atef
    Elhawi, Mai Ezzat
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 32
  • [23] Outcomes in gastric and junctional cancer using neoadjuvant and adjuvant chemotherapy (epirubicin, oxaliplatin, and capecitabine) and radical surgery
    A. M. Mongan
    R. Kalachand
    S. King
    N. J. O’Farrell
    D. Power
    N. Ravi
    C. Muldoon
    K. O’Byrne
    J. V. Reynolds
    Irish Journal of Medical Science (1971 -), 2015, 184 : 417 - 423
  • [24] Outcomes in gastric and junctional cancer using neoadjuvant and adjuvant chemotherapy (epirubicin, oxaliplatin, and capecitabine) and radical surgery
    Mongan, A. M.
    Kalachand, R.
    King, S.
    O'Farrell, N. J.
    Power, D.
    Ravi, N.
    Muldoon, C.
    O'Byrne, K.
    Reynolds, J. V.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 (02) : 417 - 423
  • [25] Phase II Trial of Concomitant Neoadjuvant Chemotherapy with Oxaliplatin and Capecitabine and Intensity-Modulated Radiotherapy (IMRT) in Rectal Cancer
    Joan Manel Gasent Blesa
    Javier Garde Noguera
    Juan Bautista Laforga Canales
    Vicent Giner Bosch
    Antonio Alberola
    Miguel Soler Tortosa
    Miguel Peris Godoy
    Jose Luis Sanchez
    Mariano Provencio Pulla
    Vicente Alberola Candel
    Journal of Gastrointestinal Cancer, 2012, 43 (4) : 553 - 561
  • [26] Neoadjuvant capecitabine and oxaliplatin (CAPOX) followed by chemoradiation (CRT) in high-risk rectal cancer: A single-institution experience
    Ahmad, Saif
    Parashar, Deepak
    Jephcott, Catherine Rachel
    Ford, Hugo
    Wilson, Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [27] Protocol amendment for ENSEMBLE study: A multicenter, randomized, phase III trial to test the superiority of consolidation irinotecan, capecitabine and oxaliplatin vs capecitabine and oxaliplatin following short course radiotherapy as total neo-adjuvant therapy in patients with locally advanced rectal cancer-Changing the irinotecan dosage
    Ando, Koji
    Watanabe, Jun
    Kagawa, Yoshinori
    Bando, Hideaki
    Kotani, Daisuke
    Suwa, Yusuke
    Nishizawa, Yujiro
    Takahashi, Yusuke
    Matsuhashi, Nobuhisa
    Suwa, Hirokazu
    Sugiyama, Masahiko
    Kanemitsu, Yukihide
    Oki, Eiji
    Uemura, Mamoru
    Yokota, Mitsuru
    Tsuboyama, Takahiro
    Oba, Koji
    Kato, Takeshi
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : TPS99 - TPS99
  • [28] Neo-adjuvant 177Lu-PSMA-I&T radionuclide in high-risk prostate cancer before radical prostatectomy: A feasibility trial
    Frumer, M.
    Rosenbaum, E.
    Kedar, D.
    Zohar, Y.
    Baniel, J.
    Steinmetz, A.
    Bernstine, H.
    Groshar, D.
    Golan, S.
    EUROPEAN UROLOGY, 2021, 79 : S1705 - S1705
  • [29] NEO-ADJUVANT 177LU-PSMA-I&T RADIONUCLIDE IN HIGH-RISK PROSTATE CANCER BEFORE RADICAL PROSTATECTOMY: A FEASIBILITY TRIAL
    Frumer, Michael
    Rosenbaum, Eli
    Kedar, Daniel
    Zohar, Yarden
    Baniel, Jack
    Steinmetz, Adam
    Bernstine, Hanna
    Groshar, David
    Golan, Shay
    JOURNAL OF UROLOGY, 2021, 206 : E271 - E271
  • [30] Preoperative capecitabine, oxaliplatin and high-dose pelvic conformal radiotherapy in locally advanced rectal cancer (LARC).
    Tucci, E
    Algeri, R
    Giulianotti, PC
    Pecci, AP
    Schiaroli, G
    Sbrana, F
    Perillo, F
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 281S - 281S
12345